Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA
Glenmark’s Ryaltris nasal spray, using Aptar Pharma’s VP3 nasal spray system, treats nasal and ocular symptoms.
Source: healthcarepackaging.com
📰 Combination Product Documentation News
Combination Product Documentation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Combination Product Documentation. Real-time updates on events, politics, business and more.
Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA
Glenmark’s Ryaltris nasal spray, using Aptar Pharma’s VP3 nasal spray system, treats nasal and ocular symptoms.
Source: healthcarepackaging.com
New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System
New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray SystemCrystal Lake, Illinois, January 27, 2022 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its VP3 multido...
Source: pharmiweb.com